Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.

Biotechnology

Ashvattha Therapeutics

Jeffrey L. Cleland

Christine S.

Steve Maricich

Mark Feng

Jennifer Herber

Jay Z.

Debra Nguyen

Jeannie Skinner

Elizabeth Torrelio

Natacha Le Moan

Jiazhong Zhang

Steve Carlos

The Leadership Team at Ashvattha Therapeutics is responsible for setting strategic direction, overseeing clinical development programs, ensuring operational efficiency, and driving the company's mission to develop innovative HD therapeutics for oncology, ophthalmology, and inflammatory diseases. This team provides executive oversight and ensures alignment across all departments to meet the company’s goals.

Leadership Team

Scientific Teams

Scientific Advisory Team

Leadership Team

About

Team members

Other teams at Ashvattha Therapeutics

Scientific Teams

Scientific Advisory Team